Thursday, February 5, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Camden National Corporation Exceeds Earnings Expectations but Faces Decline in Q4 EPS

Elaine Mendonca by Elaine Mendonca
January 31, 2024
in Breaking News
0
Banking Trading online
0
SHARES
10
VIEWS
Share on FacebookShare on Twitter

On January 30, 2024, Camden National Corporation (NASDAQ: CAC) announced its quarterly earnings, exceeding expectations with earnings of $0.85 per share, surpassing the analyst consensus estimate of $0.79 by 7.59 percent. This represents a 19.05 percent decline compared to the same period last year when earnings were $1.05 per share.

Furthermore, the company reported quarterly sales of $38.70 million, falling short of the analyst consensus estimate of $42.22 million by 8.35 percent. This reflects a 17.25 percent decrease compared to sales of $46.76 million in the same period last year.

Moving on to the financial figures for the fourth quarter of 2023, Camden National Corporation recorded a net income of $8.5 million, resulting in diluted earnings per share (EPS) of $0.58. This marks a 13 percent decrease compared to the third quarter of 2023. Additionally, the revenue net of interest expense for the quarter amounted to $38.7 million, failing to meet Street forecasts.

Overall, the company experienced a decline in diluted EPS for Q4, which dropped from $0.67 in Q3 2023.

January 30, 2024: CAC Stock Shows Stability with Slight Decline in Share Price

On January 30, 2024, CAC stock exhibited a mixed performance. According to data sourced from CNN Money, the price of CAC shares decreased by $0.47 since the market last closed, representing a 1.25% drop. The stock closed at $37.13 and remained unchanged in after-hours trading.

CAC’s position in the middle of its 52-week range suggests that the stock has not experienced any significant upward or downward movement over the past year. This can be seen as a sign of stability.

Furthermore, the fact that CAC is trading above its 200-day simple moving average is a positive indicator. When a stock is trading above its 200-day moving average, it suggests that the stock is in an uptrend or experiencing positive momentum.

However, on January 30, 2024, CAC experienced a slight decline in its share price. The stock dropped by $0.47, representing a 1.25% decrease from the previous market close. While this drop may not be significant in isolation, it indicates a slight negative shift in investor sentiment towards the stock.

Despite the decline, CAC closed at $37.13, which is still within a reasonable range. It is worth noting that after-hours trading did not witness any further movement in the stock price.

Overall, CAC’s stock performance on January 30, 2024, was relatively stable, trading within its 52-week range and above its 200-day moving average. The slight drop in share price may have been a temporary setback, and it remains to be seen how the stock will perform in the coming days and weeks. Investors should continue to monitor CAC’s price movements and consider additional factors before making any investment decisions.

CAC Stock Performance on January 30, 2024: Declining Revenue, Net Income, and EPS – What Investors Need to Know

CAC Stock Performance on January 30, 2024:

According to data from CNN Money, CAC reported a total revenue of $213.32 million for the past year, representing a 7.55% increase compared to the previous year. However, the last quarter’s total revenue stood at $62.80 million, showing a 4.89% decrease.

The net income for CAC was $61.28 million over the past year, reflecting a decline of 10.97% compared to the previous year. Similarly, the net income for the last quarter was $9.78 million, showing a decrease of 20.97% compared to the previous quarter.

The EPS for the past year was $4.17, representing a 9.33% decrease compared to the previous year. Additionally, the EPS for the last quarter was $0.67, indicating a decline of 20.94% compared to the previous quarter.

Investors and analysts will monitor CAC’s future financial reports to assess whether the recent decline in revenue, net income, and EPS is a short-term setback or a more significant trend. It’s crucial to analyze the company’s strategic initiatives, market position, and management decisions to gain a comprehensive understanding of its future prospects.

Investors should also consider other factors such as CAC’s balance sheet, cash flow, and overall market sentiment when evaluating the stock’s performance. These additional metrics can provide a more holistic view of the company’s financial health and its ability to weather short-term challenges.

In conclusion, CAC’s stock performance on January 30, 2024, showed a decline in total revenue, net income, and earnings per share compared to the previous year and quarter. Investors should closely monitor future financial reports and consider various factors before making any investment decisions related to CAC stock.

Tags: CAC
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post

Upcoming FDA Advisory Committee Meeting for Imetelstat A Groundbreaking Treatment for Malignant Stem Cells

Industrial Metals and Mining stock Trading

Annovis Bio Inc Expands Portfolio with Groundbreaking Patent Application for Mental Illness Treatment

Technology Robotics Markets and money

Carlisle Companies Incorporated Announces Sale of Carlisle Interconnect Technologies to Amphenol Corporation

Recommended

CleanSpark Stock

CleanSpark Navigates Record Profits and Regulatory Challenges

6 months ago
European Lithium Stock

Setback for European Lithium as Austrian Court Orders Fresh Environmental Review

2 months ago
Celularity Stock

Celularity Shares Extend Losses Despite Financial Restructuring

4 months ago
Juniper Networks Stock

Juniper Networks Integration Marks New Era for HPE

4 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

NextGen Healthcare: Strategic Wins and Industry Accolades Signal Sustained Momentum

Arcus Biosciences Pivots Pipeline Strategy Following Clinical Setback

National Healthcare’s Financial Report: A Crucial Test Approaches

XRP’s Dual Milestone: Regulatory Green Light Meets Core Protocol Upgrade

Coinbase Faces Mounting Pressure from Legal and Reputational Challenges

Terawulf Expands Infrastructure Portfolio with Major Site Acquisitions

Trending

NexPoint Residential Stock
Dividends

NexPoint Residential Trust Sets Date for Annual and Q4 2025 Results

by Felix Baarz
February 4, 2026
0

Investors in NexPoint Residential Trust will receive a comprehensive update on the company's performance when it releases...

PC Connection Stock

PC Connection Set to Report Full-Year and Fourth Quarter Earnings

February 4, 2026
Fossil Stock

Fossil Group Stock Surges Past Key Technical Threshold

February 4, 2026
NextGen Healthcare Stock

NextGen Healthcare: Strategic Wins and Industry Accolades Signal Sustained Momentum

February 4, 2026
Arcus Biosciences Stock

Arcus Biosciences Pivots Pipeline Strategy Following Clinical Setback

February 4, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • NexPoint Residential Trust Sets Date for Annual and Q4 2025 Results
  • PC Connection Set to Report Full-Year and Fourth Quarter Earnings
  • Fossil Group Stock Surges Past Key Technical Threshold

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com